VG
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Actionable mutations in pancreatic cancer : where targeted therapies are making a difference | BMJ open gastroenterology |  | 2025 | 1 | 0 | ||
| Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review | Clinical colorectal cancer | | 2025 | 14 | 200 | ||
| Cancer du pancréas en 2025 : prise en charge multidisciplinaire | Revue médicale suisse |  | 2025 | 48 | 0 | ||
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | | 2024 | 102 | 83 | ||
| An Overview of Cytokine Release Syndrome and Other Side Effects of CAR-T Cell Therapy | Praxis | | 2023 | 119 | 0 | ||
| Novel pathophysiological insights into CAR-T cell associated neurotoxicity | Frontiers in neurology | | 2023 | 170 | 226 | ||
| Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies | International Journal of Molecular Sciences | | 2021 | 260 | 328 | ||
| Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma | Journal for immunotherapy of cancer | | 2021 | 277 | 250 | ||
| Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | | 2021 | 263 | 190 | ||
| Improved glioblastoma mouse models to design better immunotherapeutic combinations | | 2019 | 622 | 178 | |||
| Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | | 2018 | 434 | 1 |
